SUVOREXANT

SUVOREXANT was reported 13031 times

These side effects are most commonly reported by patients taking SUVOREXANT:

# Side effect Count
0 DRUG INEFFECTIVE 3050
1 NIGHTMARE 743
2 SOMNOLENCE 738
3 INSOMNIA 688
4 ABNORMAL DREAMS 603
5 HEADACHE 549
6 FEELING ABNORMAL 489
7 NAUSEA 395
8 NO ADVERSE EVENT 389
9 HALLUCINATION 380
10 FATIGUE 365
11 DIZZINESS 341
12 ANXIETY 317
13 OFF LABEL USE 275
14 FALL 272
15 PRODUCT DOSE OMISSION ISSUE 257
16 MALAISE 248
17 DIARRHOEA 245
18 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 235
19 SLEEP PARALYSIS 233
20 POOR QUALITY SLEEP 227
21 PRODUCT USE ISSUE 217
22 ADVERSE EVENT 208
23 OVERDOSE 199
24 SLEEP DISORDER 199
25 DYSPNOEA 198
26 DEPRESSION 189
27 VOMITING 182
28 MIDDLE INSOMNIA 177
29 DELIRIUM 167
30 PAIN 163
31 PYREXIA 159
32 AGITATION 156
33 DRUG EFFECT INCOMPLETE 152
34 DECREASED APPETITE 149
35 PNEUMONIA 145
36 PALPITATIONS 141
37 SOMNAMBULISM 141
38 RASH 135
39 TREMOR 134
40 CONFUSIONAL STATE 131
41 SUICIDAL IDEATION 131
42 DRUG DOSE OMISSION 130
43 PRODUCT USE IN UNAPPROVED INDICATION 128
44 DEATH 123
45 PRURITUS 121
46 DRUG INTERACTION 120
47 ASTHENIA 113
48 MEMORY IMPAIRMENT 111
49 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 106
50 INTENTIONAL OVERDOSE 105
51 CONSTIPATION 104
52 LOSS OF CONSCIOUSNESS 101
53 GAIT DISTURBANCE 98
54 DRY MOUTH 97
55 WEIGHT DECREASED 97
56 HYPERTENSION 93
57 INTERSTITIAL LUNG DISEASE 93
58 WEIGHT INCREASED 93
59 HEPATIC FUNCTION ABNORMAL 92
60 RENAL IMPAIRMENT 91
61 INITIAL INSOMNIA 90
62 PRODUCT DOSE OMISSION 90
63 SEIZURE 90
64 MUSCULAR WEAKNESS 89
65 AMNESIA 88
66 PAIN IN EXTREMITY 88
67 TOXICITY TO VARIOUS AGENTS 88
68 ABDOMINAL DISCOMFORT 87
69 ARTHRALGIA 87
70 ALTERED STATE OF CONSCIOUSNESS 86
71 RESTLESSNESS 86
72 ANAEMIA 83
73 COMPLETED SUICIDE 83
74 IRRITABILITY 82
75 CONDITION AGGRAVATED 81
76 COUGH 81
77 PRODUCT QUALITY ISSUE 81
78 CARDIAC FAILURE 80
79 PRODUCT PACKAGING QUANTITY ISSUE 79
80 INTENTIONAL PRODUCT MISUSE 78
81 SUICIDE ATTEMPT 78
82 UNDERDOSE 75
83 HYPOAESTHESIA 74
84 DEHYDRATION 73
85 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 73
86 URINARY TRACT INFECTION 73
87 ABDOMINAL PAIN UPPER 72
88 DEPRESSED LEVEL OF CONSCIOUSNESS 72
89 HYPERHIDROSIS 71
90 INCORRECT DOSE ADMINISTERED 71
91 MUSCLE SPASMS 71
92 ABNORMAL BEHAVIOUR 69
93 BLOOD PRESSURE INCREASED 65
94 MOVEMENT DISORDER 65
95 ACUTE KIDNEY INJURY 64
96 HANGOVER 64
97 MIGRAINE 64
98 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64
99 BLOOD PRESSURE DECREASED 63
100 BACK PAIN 62
101 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 61
102 BALANCE DISORDER 58
103 CHEST PAIN 58
104 MYALGIA 58
105 PNEUMONIA ASPIRATION 58
106 DYSPHAGIA 57
107 PARAESTHESIA 57
108 DYSKINESIA 55
109 ERYTHEMA 55
110 NASOPHARYNGITIS 55
111 THERAPEUTIC RESPONSE UNEXPECTED 55
112 CHEST DISCOMFORT 54
113 FEELING JITTERY 54
114 ABDOMINAL PAIN 53
115 HEART RATE INCREASED 53
116 THERAPEUTIC RESPONSE DECREASED 53
117 URINARY RETENTION 53
118 NERVOUSNESS 52
119 HYPERSOMNIA 51
120 LIVER DISORDER 51
121 CEREBRAL INFARCTION 50
122 SEDATION 50
123 SLEEP TERROR 50
124 COVID-19 49
125 DRUG EFFECT DECREASED 49
126 FEAR 49
127 PLATELET COUNT DECREASED 49
128 RHABDOMYOLYSIS 48
129 TINNITUS 48
130 DISTURBANCE IN ATTENTION 47
131 MALIGNANT NEOPLASM PROGRESSION 46
132 PARALYSIS 46
133 THERAPEUTIC PRODUCT EFFECT DECREASED 46
134 VISUAL IMPAIRMENT 46
135 HALLUCINATION, AUDITORY 45
136 RESTLESS LEGS SYNDROME 45
137 HYPOGLYCAEMIA 44
138 ILL-DEFINED DISORDER 44
139 INTENTIONAL PRODUCT USE ISSUE 44
140 RENAL FAILURE 44
141 SPEECH DISORDER 44
142 AGGRESSION 43
143 CHRONIC KIDNEY DISEASE 43
144 SEPSIS 43
145 PRODUCT AVAILABILITY ISSUE 42
146 CONTUSION 41
147 DRUG ERUPTION 41
148 OEDEMA PERIPHERAL 41
149 THINKING ABNORMAL 41
150 DEPRESSED MOOD 40
151 HEAD INJURY 40
152 HYPOKALAEMIA 40
153 NIGHT SWEATS 40
154 PANIC ATTACK 40
155 POLLAKIURIA 40
156 HYPONATRAEMIA 39
157 MENTAL DISORDER 39
158 URTICARIA 39
159 ABNORMAL SLEEP-RELATED EVENT 38
160 DRUG HYPERSENSITIVITY 38
161 STRESS 38
162 VISION BLURRED 38
163 CATAPLEXY 37
164 CRYING 37
165 DEMENTIA 37
166 DISORIENTATION 37
167 DRUG EFFECT DELAYED 36
168 HOSPITALISATION 36
169 HYPERSENSITIVITY 36
170 HYPOTENSION 36
171 INJECTION SITE PAIN 36
172 MUSCULOSKELETAL STIFFNESS 36
173 PSYCHOMOTOR HYPERACTIVITY 36
174 ANGER 35
175 BRADYCARDIA 35
176 GASTROOESOPHAGEAL REFLUX DISEASE 35
177 HEAD DISCOMFORT 35
178 INABILITY TO AFFORD MEDICATION 35
179 INFECTION 35
180 PRESCRIBED OVERDOSE 35
181 ALOPECIA 34
182 ATRIAL FIBRILLATION 34
183 DYSARTHRIA 34
184 DYSGEUSIA 34
185 DYSPEPSIA 34
186 ROAD TRAFFIC ACCIDENT 34
187 CONTRAINDICATED PRODUCT ADMINISTERED 33
188 DIABETES MELLITUS 33
189 LETHARGY 33
190 PERIPHERAL SWELLING 33
191 CHILLS 32
192 INFLUENZA 32
193 NEUROPATHY PERIPHERAL 32
194 SLEEP APNOEA SYNDROME 32
195 DRUG-INDUCED LIVER INJURY 31
196 ILLNESS 31
197 EATING DISORDER 30
198 MOBILITY DECREASED 30
199 PARKINSON^S DISEASE 30
200 PRESCRIBED UNDERDOSE 30
201 PRODUCT BLISTER PACKAGING ISSUE 30
202 SYNCOPE 30
203 COGNITIVE DISORDER 29
204 HALLUCINATION, VISUAL 29
205 ADVERSE DRUG REACTION 28
206 BLOOD GLUCOSE INCREASED 28
207 DRUG DEPENDENCE 28
208 WHITE BLOOD CELL COUNT DECREASED 28
209 ARTHRITIS 27
210 CARDIAC ARREST 27
211 DRUG EFFECT LESS THAN EXPECTED 27
212 DYSPHONIA 27
213 MULTIPLE SCLEROSIS RELAPSE 27
214 MYOCARDIAL INFARCTION 27
215 PRODUCT PRESCRIBING ISSUE 27
216 PRODUCT STORAGE ERROR 27
217 SINUSITIS 27
218 BIPOLAR DISORDER 26
219 BURNING SENSATION 26
220 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26
221 DRUG INTOLERANCE 26
222 EYE PAIN 26
223 GENERAL PHYSICAL HEALTH DETERIORATION 26
224 MENTAL IMPAIRMENT 26
225 MOOD ALTERED 26
226 NECK PAIN 26
227 NEUROLEPTIC MALIGNANT SYNDROME 26
228 PARKINSONISM 26
229 POOR QUALITY PRODUCT ADMINISTERED 26
230 SURGERY 26
231 TACHYCARDIA 26
232 ABDOMINAL DISTENSION 25
233 FLUSHING 25
234 MULTIPLE SCLEROSIS 25
235 NEUTROPHIL COUNT DECREASED 25
236 ASPARTATE AMINOTRANSFERASE INCREASED 24
237 BRONCHITIS 24
238 CELLULITIS 24
239 HOT FLUSH 24
240 LUNG DISORDER 24
241 OROPHARYNGEAL PAIN 24
242 PLEURAL EFFUSION 24
243 THERAPEUTIC PRODUCT EFFECT DELAYED 24
244 WRONG TECHNIQUE IN DRUG USAGE PROCESS 24
245 ACCIDENTAL OVERDOSE 23
246 ASPHYXIA 23
247 ASTHMA 23
248 BLOOD CREATINE PHOSPHOKINASE INCREASED 23
249 DRUG ADMINISTRATION ERROR 23
250 DRUG LEVEL INCREASED 23
251 DRY EYE 23
252 ELECTROCARDIOGRAM QT PROLONGED 23
253 HEPATIC ENZYME INCREASED 23
254 HYPOPHAGIA 23
255 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23
256 NOCTURIA 23
257 THERAPY NON-RESPONDER 23
258 ALANINE AMINOTRANSFERASE INCREASED 22
259 APHASIA 22
260 CEREBROVASCULAR ACCIDENT 22
261 FEELING DRUNK 22
262 GASTROINTESTINAL HAEMORRHAGE 22
263 TREATMENT FAILURE 22
264 UPPER RESPIRATORY TRACT INFECTION 22
265 BLOOD GLUCOSE DECREASED 21
266 CARDIAC DISORDER 21
267 FEEDING DISORDER 21
268 HAEMOGLOBIN DECREASED 21
269 HYPERKALAEMIA 21
270 MANIA 21
271 PSYCHOTIC DISORDER 21
272 RESPIRATORY FAILURE 21
273 SCREAMING 21
274 THROMBOCYTOPENIA 21
275 TREATMENT NONCOMPLIANCE 21
276 URINARY INCONTINENCE 21
277 VERTIGO 21
278 CEREBRAL HAEMORRHAGE 20
279 DISCOMFORT 20
280 EPILEPSY 20
281 EYE IRRITATION 20
282 GLYCOSYLATED HAEMOGLOBIN INCREASED 20
283 HERPES ZOSTER 20
284 INTENTIONAL UNDERDOSE 20
285 ORTHOSTATIC HYPOTENSION 20
286 PANCYTOPENIA 20
287 PRODUCT USE COMPLAINT 20
288 RENAL DISORDER 20
289 SCHIZOPHRENIA 20
290 STOMATITIS 20
291 SWELLING FACE 20
292 UNEVALUABLE EVENT 20
293 ANGINA PECTORIS 19
294 BLOOD CREATININE INCREASED 19
295 EMOTIONAL DISTRESS 19
296 ERYTHEMA MULTIFORME 19
297 EXPIRED PRODUCT ADMINISTERED 19
298 GASTROINTESTINAL DISORDER 19
299 NEPHROLITHIASIS 19
300 PHYSICAL DECONDITIONING 19
301 PNEUMONIA BACTERIAL 19
302 PRODUCT PACKAGING DIFFICULT TO OPEN 19
303 PSYCHIATRIC SYMPTOM 19
304 THERAPY CESSATION 19
305 ADVERSE REACTION 18
306 AKATHISIA 18
307 ANAPHYLACTIC REACTION 18
308 ASPIRATION 18
309 CARDIO-RESPIRATORY ARREST 18
310 COLD SWEAT 18
311 CONTRAINDICATED PRODUCT PRESCRIBED 18
312 DELUSION 18
313 DRUG ABUSE 18
314 DRUG PRESCRIBING ERROR 18
315 FEMORAL NECK FRACTURE 18
316 HYPERGLYCAEMIA 18
317 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18
318 OEDEMA 18
319 OSTEOARTHRITIS 18
320 PANIC REACTION 18
321 PRURITUS GENERALISED 18
322 SEPTIC SHOCK 18
323 SUBDURAL HAEMATOMA 18
324 TACHYPHRENIA 18
325 TERMINAL INSOMNIA 18
326 WITHDRAWAL SYNDROME 18
327 ARRHYTHMIA 17
328 C-REACTIVE PROTEIN INCREASED 17
329 CHOLANGITIS 17
330 COMA 17
331 CONCUSSION 17
332 DISEASE PROGRESSION 17
333 DIZZINESS POSTURAL 17
334 DYSSTASIA 17
335 FEBRILE NEUTROPENIA 17
336 GAIT INABILITY 17
337 HAEMOPTYSIS 17
338 HYPOTHYROIDISM 17
339 IMPAIRED GASTRIC EMPTYING 17
340 INJECTION SITE ERYTHEMA 17
341 LIMB DISCOMFORT 17
342 OXYGEN SATURATION DECREASED 17
343 PRODUCT SUPPLY ISSUE 17
344 PSORIASIS 17
345 SEDATION COMPLICATION 17
346 SENSORY DISTURBANCE 17
347 SEROTONIN SYNDROME 17
348 SLUGGISHNESS 17
349 SWOLLEN TONGUE 17
350 THIRST 17
351 ADRENAL INSUFFICIENCY 16
352 DYSURIA 16
353 ECZEMA 16
354 EPISTAXIS 16
355 FEMUR FRACTURE 16
356 FLATULENCE 16
357 FRUSTRATION TOLERANCE DECREASED 16
358 HELICOBACTER INFECTION 16
359 INTENTIONAL SELF-INJURY 16
360 LIP SWELLING 16
361 LUNG NEOPLASM MALIGNANT 16
362 MUSCLE TWITCHING 16
363 PEMPHIGOID 16
364 PRODUCT PACKAGING ISSUE 16
365 SLEEP-RELATED EATING DISORDER 16
366 SPINAL COMPRESSION FRACTURE 16
367 BONE PAIN 15
368 CARDIAC FAILURE ACUTE 15
369 ENURESIS 15
370 FEELING COLD 15
371 INSURANCE ISSUE 15
372 PARADOXICAL DRUG REACTION 15
373 RASH PRURITIC 15
374 RIB FRACTURE 15
375 SLEEP TALKING 15
376 STUPOR 15
377 THERAPEUTIC RESPONSE INCREASED 15
378 APATHY 14
379 BLOOD PRESSURE FLUCTUATION 14
380 CARDIAC FAILURE CONGESTIVE 14
381 DISSEMINATED INTRAVASCULAR COAGULATION 14
382 EMOTIONAL DISORDER 14
383 FEELING HOT 14
384 HYPERVENTILATION 14
385 HYPOACUSIS 14
386 IMPAIRED DRIVING ABILITY 14
387 INCOHERENT 14
388 INCREASED APPETITE 14
389 INFLUENZA LIKE ILLNESS 14
390 LIMB INJURY 14
391 MEDICATION ERROR 14
392 PALLOR 14
393 PARANOIA 14
394 PRE-EXISTING CONDITION IMPROVED 14
395 PULMONARY OEDEMA 14
396 RHINORRHOEA 14
397 STEVENS-JOHNSON SYNDROME 14
398 TARDIVE DYSKINESIA 14
399 THERAPEUTIC RESPONSE DELAYED 14
400 WHEEZING 14
401 BLISTER 13
402 BLOOD POTASSIUM DECREASED 13
403 CARDIAC FAILURE CHRONIC 13
404 COLON CANCER 13
405 DRUG RESISTANCE 13
406 EUPHORIC MOOD 13
407 FORMICATION 13
408 HAEMORRHOIDS 13
409 INFLAMMATION 13
410 INFUSION SITE PAIN 13
411 MUSCULOSKELETAL PAIN 13
412 NO THERAPEUTIC RESPONSE 13
413 PNEUMONITIS 13
414 PULMONARY ARTERIAL HYPERTENSION 13
415 RESPIRATORY DEPRESSION 13
416 SKIN EXFOLIATION 13
417 SUDDEN DEATH 13
418 THERAPY INTERRUPTED 13
419 TOXIC EPIDERMAL NECROLYSIS 13
420 TRANSIENT ISCHAEMIC ATTACK 13
421 CATARACT 12
422 CHOKING 12
423 COMPRESSION FRACTURE 12
424 DECUBITUS ULCER 12
425 DEPRESSIVE SYMPTOM 12
426 DEVICE DISLOCATION 12
427 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12
428 DYSPNOEA EXERTIONAL 12
429 EAR INFECTION 12
430 FLUID RETENTION 12
431 HAEMORRHAGE 12
432 HYPOAESTHESIA ORAL 12
433 ILEUS 12
434 INFUSION RELATED REACTION 12
435 INTENTIONAL DOSE OMISSION 12
436 JOINT SWELLING 12
437 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12
438 LYMPHOCYTE COUNT DECREASED 12
439 MYOCLONUS 12
440 PHARYNGEAL OEDEMA 12
441 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12
442 PRODUCT DOSE OMISSION IN ERROR 12
443 PULMONARY EMBOLISM 12
444 RASH GENERALISED 12
445 SKIN LACERATION 12
446 ANAPHYLACTIC SHOCK 11
447 APNOEA 11
448 BLOOD CHOLESTEROL INCREASED 11
449 COLITIS 11
450 CONCOMITANT DISEASE AGGRAVATED 11
451 DEEP VEIN THROMBOSIS 11
452 DERMATITIS CONTACT 11
453 DIPLOPIA 11
454 DISABILITY 11
455 DIVERTICULITIS 11
456 DYSLIPIDAEMIA 11
457 ECONOMIC PROBLEM 11
458 EXTRA DOSE ADMINISTERED 11
459 FOETAL EXPOSURE DURING PREGNANCY 11
460 FUNGAL INFECTION 11
461 GASTRIC DISORDER 11
462 GENERALISED TONIC-CLONIC SEIZURE 11
463 GLAUCOMA 11
464 HEART RATE DECREASED 11
465 INCONTINENCE 11
466 INJURY 11
467 JOINT INJURY 11
468 LOSS OF THERAPEUTIC RESPONSE 11
469 LYMPHADENOPATHY 11
470 NARCOLEPSY 11
471 NEOPLASM MALIGNANT 11
472 NEURALGIA 11
473 PLEUROTHOTONUS 11
474 PYELONEPHRITIS 11
475 RADIATION PNEUMONITIS 11
476 RESPIRATORY ARREST 11
477 RESPIRATORY DISORDER 11
478 RESPIRATORY TRACT INFECTION 11
479 SKIN DISORDER 11
480 SUSPECTED SUICIDE 11
481 TENSION 11
482 THROMBOSIS 11
483 ANAL INCONTINENCE 10
484 BLOOD BILIRUBIN INCREASED 10
485 DEVICE ISSUE 10
486 DIABETIC KETOACIDOSIS 10
487 DISSOCIATION 10
488 DRUG EFFECT VARIABLE 10
489 DRY SKIN 10
490 ENCEPHALOPATHY 10
491 ERECTILE DYSFUNCTION 10
492 EYE SWELLING 10
493 HAEMATURIA 10
494 HAEMORRHAGE SUBCUTANEOUS 10
495 HEPATIC FAILURE 10
496 IMPAIRED WORK ABILITY 10
497 INJECTION SITE INDURATION 10
498 INTERNATIONAL NORMALISED RATIO INCREASED 10
499 INTESTINAL OBSTRUCTION 10
500 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10
501 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 10
502 MATERNAL EXPOSURE DURING PREGNANCY 10
503 MELAENA 10
504 MENTAL STATUS CHANGES 10
505 NASAL CONGESTION 10
506 OCULAR HYPERAEMIA 10
507 OSTEONECROSIS OF JAW 10
508 OSTEOPOROSIS 10
509 PERITONITIS 10
510 PNEUMOTHORAX 10
511 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10
512 PRODUCT PRESCRIBING ERROR 10
513 PROSTATE CANCER 10
514 PULMONARY ALVEOLAR HAEMORRHAGE 10
515 PULMONARY CONGESTION 10
516 SNORING 10
517 SWELLING 10
518 THROAT TIGHTNESS 10
519 TUBULOINTERSTITIAL NEPHRITIS 10
520 ACNE 9
521 AGEUSIA 9
522 ARTHROPATHY 9
523 BENIGN PROSTATIC HYPERPLASIA 9
524 BLOOD ALKALINE PHOSPHATASE INCREASED 9
525 BLOOD LACTATE DEHYDROGENASE INCREASED 9
526 BRADYKINESIA 9
527 CANCER PAIN 9
528 CEREBRAL DISORDER 9
529 CHOLECYSTITIS 9
530 CHOLELITHIASIS 9
531 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9
532 COVID-19 PNEUMONIA 9
533 CYTOKINE RELEASE SYNDROME 9
534 DRUG SCREEN POSITIVE 9
535 DRUG TOLERANCE 9
536 DRUG WITHDRAWAL SYNDROME 9
537 ELECTROLYTE IMBALANCE 9
538 ENERGY INCREASED 9
539 ENTEROCOLITIS 9
540 EXPOSURE DURING PREGNANCY 9
541 EYE DISORDER 9
542 FIBROMYALGIA 9
543 FRACTURE 9
544 GASTRIC ULCER 9
545 GASTROENTERITIS 9
546 HEAT ILLNESS 9
547 HEPATIC ENCEPHALOPATHY 9
548 HERNIA 9
549 HYPERCALCAEMIA 9
550 HYPERPHAGIA 9
551 HYPERVIGILANCE 9
552 IMMUNE-MEDIATED HEPATIC DISORDER 9
553 IMPAIRED HEALING 9
554 INTESTINAL ISCHAEMIA 9
555 JAUNDICE 9
556 KIDNEY INFECTION 9
557 MUSCULOSKELETAL DISCOMFORT 9
558 MYASTHENIA GRAVIS 9
559 NEUTROPENIA 9
560 ON AND OFF PHENOMENON 9
561 PAIN IN JAW 9
562 PANIC DISORDER 9
563 PERICARDIAL EFFUSION 9
564 PHOTOPSIA 9
565 PRODUCT ADMINISTRATION INTERRUPTED 9
566 PRODUCTIVE COUGH 9
567 PULMONARY TOXICITY 9
568 RASH ERYTHEMATOUS 9
569 RHEUMATOID ARTHRITIS 9
570 SALIVARY HYPERSECRETION 9
571 STAPHYLOCOCCAL INFECTION 9
572 SUICIDAL BEHAVIOUR 9
573 THERAPEUTIC PRODUCT EFFECT INCREASED 9
574 VISUAL ACUITY REDUCED 9
575 WHITE BLOOD CELL COUNT INCREASED 9
576 WOUND 9
577 ACTIVITIES OF DAILY LIVING IMPAIRED 8
578 ACUTE MYOCARDIAL INFARCTION 8
579 AKINESIA 8
580 ANHEDONIA 8
581 CHRONIC GASTRITIS 8
582 COLITIS ISCHAEMIC 8
583 CYTOMEGALOVIRUS INFECTION 8
584 DEAFNESS 8
585 DRUG EFFECT PROLONGED 8
586 END STAGE RENAL DISEASE 8
587 GASTROINTESTINAL NECROSIS 8
588 HAEMATOCHEZIA 8
589 HYPNAGOGIC HALLUCINATION 8
590 INCORRECT DOSAGE ADMINISTERED 8
591 INJECTION SITE SWELLING 8
592 INTERVERTEBRAL DISC PROTRUSION 8
593 LACRIMATION INCREASED 8
594 LARGE INTESTINE PERFORATION 8
595 LARGE INTESTINE POLYP 8
596 LIVER ABSCESS 8
597 MICTURITION URGENCY 8
598 MULTIPLE ALLERGIES 8
599 NEEDLE ISSUE 8
600 NEPHROGENIC ANAEMIA 8
601 OBSESSIVE-COMPULSIVE DISORDER 8
602 OCULAR DISCOMFORT 8
603 OESOPHAGEAL DILATATION 8
604 PRODUCT DISTRIBUTION ISSUE 8
605 PRODUCT LABEL ISSUE 8
606 PSORIATIC ARTHROPATHY 8
607 RENAL INJURY 8
608 RIGHT VENTRICULAR FAILURE 8
609 SCRATCH 8
610 SHOCK 8
611 SKIN HAEMORRHAGE 8
612 SUBARACHNOID HAEMORRHAGE 8
613 SUDDEN ONSET OF SLEEP 8
614 SUPRAVENTRICULAR TACHYCARDIA 8
615 THERAPEUTIC RESPONSE SHORTENED 8
616 TYPE 2 DIABETES MELLITUS 8
617 VENTRICULAR EXTRASYSTOLES 8
618 AFFECT LABILITY 7
619 AGRANULOCYTOSIS 7
620 ANXIETY DISORDER 7
621 BACK DISORDER 7
622 BEDRIDDEN 7
623 BLEPHAROSPASM 7
624 BLINDNESS 7
625 BLOOD SODIUM DECREASED 7
626 BLOOD UREA INCREASED 7
627 BONE MARROW FAILURE 7
628 BRAIN CONTUSION 7
629 BRUXISM 7
630 CARPAL TUNNEL SYNDROME 7
631 CENTRAL HYPOTHYROIDISM 7
632 CIRCADIAN RHYTHM SLEEP DISORDER 7
633 CYSTITIS 7
634 DEVICE OCCLUSION 7
635 DEVICE RELATED INFECTION 7
636 DIPLEGIA 7
637 DRY THROAT 7
638 DYSPHORIA 7
639 ENTERITIS INFECTIOUS 7
640 FACIAL PARALYSIS 7
641 FOOT FRACTURE 7
642 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7
643 GASTRIC CANCER 7
644 GASTROINTESTINAL INFECTION 7
645 HEART RATE ABNORMAL 7
646 HEPATIC STEATOSIS 7
647 HYPERTHYROIDISM 7
648 INCORRECT PRODUCT STORAGE 7
649 JOINT STIFFNESS 7
650 KNEE ARTHROPLASTY 7
651 LABELLED DRUG-DRUG INTERACTION ISSUE 7
652 LIGAMENT SPRAIN 7
653 LISTLESS 7
654 LIVER FUNCTION TEST ABNORMAL 7
655 MALNUTRITION 7
656 MARASMUS 7
657 METABOLIC DISORDER 7
658 METASTASES TO CENTRAL NERVOUS SYSTEM 7
659 MOOD SWINGS 7
660 MUSCLE TIGHTNESS 7
661 MYELODYSPLASTIC SYNDROME 7
662 MYOSITIS 7
663 NEPHROTIC SYNDROME 7
664 ORAL CANDIDIASIS 7
665 ORAL DISCOMFORT 7
666 PANCREATITIS ACUTE 7
667 PARAESTHESIA ORAL 7
668 PHOTOPHOBIA 7
669 PNEUMOCYSTIS JIROVECII PNEUMONIA 7
670 POISONING DELIBERATE 7
671 POST-TRAUMATIC STRESS DISORDER 7
672 PRODUCT ADMINISTRATION ERROR 7
673 PROTEINURIA 7
674 PULMONARY MASS 7
675 RECTAL HAEMORRHAGE 7
676 RESPIRATION ABNORMAL 7
677 ROTATOR CUFF SYNDROME 7
678 SEASONAL ALLERGY 7
679 SENSITIVE SKIN 7
680 SHOCK HAEMORRHAGIC 7
681 SINUS CONGESTION 7
682 SINUS DISORDER 7
683 SKIN DISCOLOURATION 7
684 SMALL INTESTINAL HAEMORRHAGE 7
685 SPINAL OPERATION 7
686 SYSTEMIC LUPUS ERYTHEMATOSUS 7
687 TASTE DISORDER 7
688 THERAPEUTIC PRODUCT EFFECT VARIABLE 7
689 THERAPY CHANGE 7
690 THROAT IRRITATION 7
691 TOOTHACHE 7
692 TOXIC SKIN ERUPTION 7
693 ULCER HAEMORRHAGE 7
694 UPPER LIMB FRACTURE 7
695 VIRAL INFECTION 7
696 ACCIDENT 6
697 ANKLE FRACTURE 6
698 ANTEROGRADE AMNESIA 6
699 AUTOSCOPY 6
700 BACTERIAL INFECTION 6
701 BEHAVIOUR DISORDER 6
702 BRAIN FOG 6
703 BREAST CANCER 6
704 CARDIOMEGALY 6
705 CARDIOMYOPATHY 6
706 CHOLECYSTITIS ACUTE 6
707 COLITIS ULCERATIVE 6
708 CROHN^S DISEASE 6
709 DECREASED ACTIVITY 6
710 DEMENTIA ALZHEIMER^S TYPE 6
711 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6
712 DYSTONIA 6
713 ERUCTATION 6
714 ESCHERICHIA INFECTION 6
715 EYE CONTUSION 6
716 FACE OEDEMA 6
717 FAECES DISCOLOURED 6
718 GLUCOSE TOLERANCE IMPAIRED 6
719 HAEMATEMESIS 6
720 HAEMATOCRIT DECREASED 6
721 HAEMOGLOBIN INCREASED 6
722 HAEMOLYTIC ANAEMIA 6
723 HEART RATE IRREGULAR 6
724 HIP FRACTURE 6
725 HUNGER 6
726 HYPERTONIC BLADDER 6
727 HYPOCALCAEMIA 6
728 ILEUS PARALYTIC 6
729 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6
730 INFECTIOUS PLEURAL EFFUSION 6
731 INGUINAL HERNIA 6
732 INJECTION SITE PRURITUS 6
733 JOINT DISLOCATION 6
734 LABELLED DRUG-FOOD INTERACTION ISSUE 6
735 LACERATION 6
736 LYMPHOMA 6
737 METASTASES TO LIVER 6
738 METASTASES TO LUNG 6
739 MUSCLE FATIGUE 6
740 MUSCLE RIGIDITY 6
741 OBESITY 6
742 OESOPHAGITIS 6
743 OROPHARYNGEAL DISCOMFORT 6
744 OSTEOMYELITIS 6
745 PANCREATIC CARCINOMA 6
746 PANCREATITIS 6
747 PERIPHERAL COLDNESS 6
748 PHYSICAL DISABILITY 6
749 POSTURE ABNORMAL 6
750 PRODUCT DISPENSING ERROR 6
751 PRODUCT DISPENSING ISSUE 6
752 PRODUCT SUBSTITUTION ISSUE 6
753 PRODUCT TASTE ABNORMAL 6
754 PROSTATIC DISORDER 6
755 PULMONARY HYPERTENSION 6
756 PURPURA 6
757 RADIUS FRACTURE 6
758 RASH PAPULAR 6
759 RETCHING 6
760 SLEEP DEFICIT 6
761 SPINAL OSTEOARTHRITIS 6
762 STOMA SITE DISCHARGE 6
763 STOMA SITE HYPERGRANULATION 6
764 SUSPECTED COVID-19 6
765 TEMPERATURE INTOLERANCE 6
766 TENDERNESS 6
767 THYROID DISORDER 6
768 THYROIDITIS 6
769 TUMOUR HAEMORRHAGE 6
770 VITAMIN D DECREASED 6
771 ACUTE RESPIRATORY DISTRESS SYNDROME 5
772 ACUTE RESPIRATORY FAILURE 5
773 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5
774 AFFECTIVE DISORDER 5
775 ANGIOPATHY 5
776 APHONIA 5
777 ARTERIOSCLEROSIS 5
778 ATRIOVENTRICULAR BLOCK COMPLETE 5
779 AUTOIMMUNE HEPATITIS 5
780 BACTERAEMIA 5
781 BLOOD PRESSURE SYSTOLIC INCREASED 5
782 BLOOD TRIGLYCERIDES INCREASED 5
783 COAGULOPATHY 5
784 CONJUNCTIVITIS 5
785 CORONARY ARTERY DISEASE 5
786 CORONAVIRUS INFECTION 5
787 CYTOPENIA 5
788 DENTAL CARIES 5
789 DEPENDENCE 5
790 DERMATITIS EXFOLIATIVE GENERALISED 5
791 DEVICE BREAKAGE 5
792 DEVICE LEAKAGE 5
793 DIABETES MELLITUS INADEQUATE CONTROL 5
794 DIABETIC NEUROPATHY 5
795 DISEASE RECURRENCE 5
796 DIVERTICULUM INTESTINAL 5
797 DRUG EFFECT INCREASED 5
798 DRUG SCREEN FALSE POSITIVE 5
799 DRUG WITHDRAWAL SYNDROME NEONATAL 5
800 DUODENAL ULCER 5
801 EMPHYSEMA 5
802 EOSINOPHIL COUNT INCREASED 5
803 EXTRAPYRAMIDAL DISORDER 5
804 EYE MOVEMENT DISORDER 5
805 FACIAL BONES FRACTURE 5
806 FACIAL SPASM 5
807 FAECES SOFT 5
808 FOOD INTERACTION 5
809 GASTRIC ULCER HAEMORRHAGE 5
810 GASTROENTERITIS VIRAL 5
811 GASTROINTESTINAL PERFORATION 5
812 GLOMERULAR FILTRATION RATE DECREASED 5
813 GLOSSOPTOSIS 5
814 HAEMATOMA 5
815 HAEMOLYSIS 5
816 HICCUPS 5
817 HIP ARTHROPLASTY 5
818 HUMERUS FRACTURE 5
819 HYPERNATRAEMIA 5
820 HYPERPROLACTINAEMIA 5
821 HYPERURICAEMIA 5
822 HYPOKINESIA 5
823 HYPOPITUITARISM 5
824 HYPOTONIA 5
825 IMMUNE SYSTEM DISORDER 5
826 INCORRECT ROUTE OF DRUG ADMINISTRATION 5
827 INJECTION SITE BRUISING 5
828 INJECTION SITE RASH 5
829 INJECTION SITE REACTION 5
830 IRON DEFICIENCY ANAEMIA 5
831 JUDGEMENT IMPAIRED 5
832 LACTIC ACIDOSIS 5
833 LOCALISED INFECTION 5
834 LUMBAR SPINAL STENOSIS 5
835 LUNG ADENOCARCINOMA 5
836 METASTASES TO LYMPH NODES 5
837 MOANING 5
838 MONOPLEGIA 5
839 MUSCLE CONTRACTIONS INVOLUNTARY 5
840 MUSCULOSKELETAL DISORDER 5
841 MYOPATHY 5
842 OCULOGYRIC CRISIS 5
843 OSTEOPENIA 5
844 PARASOMNIA 5
845 PERIODIC LIMB MOVEMENT DISORDER 5
846 PERIPHERAL SENSORY NEUROPATHY 5
847 PHOTOSENSITIVITY REACTION 5
848 PLEURISY 5
849 PNEUMATOSIS INTESTINALIS 5
850 POLYDIPSIA 5
851 POLYURIA 5
852 POST PROCEDURAL COMPLICATION 5
853 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5
854 PRODUCT COLOUR ISSUE 5
855 PRODUCT CONTAINER ISSUE 5
856 PRODUCT PHYSICAL ISSUE 5
857 PROTHROMBIN TIME PROLONGED 5
858 RED BLOOD CELL COUNT DECREASED 5
859 SCIATICA 5
860 SJOGREN^S SYNDROME 5
861 SKIN ABRASION 5
862 SKIN ULCER 5
863 SMALL INTESTINAL OBSTRUCTION 5
864 SPINAL DISORDER 5
865 SPINAL STENOSIS 5
866 SPONTANEOUS PENILE ERECTION 5
867 STEROID DIABETES 5
868 STOMA SITE ERYTHEMA 5
869 STOMA SITE INFECTION 5
870 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5
871 SWELLING OF EYELID 5
872 TENSION HEADACHE 5
873 THERAPY PARTIAL RESPONDER 5
874 THERMAL BURN 5
875 TIME PERCEPTION ALTERED 5
876 TOOTH DISORDER 5
877 TOOTH EXTRACTION 5
878 UPPER-AIRWAY COUGH SYNDROME 5
879 VANISHING BILE DUCT SYNDROME 5
880 VENTRICULAR TACHYCARDIA 5
881 VITAMIN B12 DEFICIENCY 5
882 ABASIA 4
883 ABULIA 4
884 ACCIDENTAL EXPOSURE TO PRODUCT 4
885 ACIDOSIS 4
886 ANOSMIA 4
887 APHTHOUS ULCER 4
888 APPENDICITIS 4
889 ASCITES 4
890 ATAXIA 4
891 ATRIOVENTRICULAR BLOCK 4
892 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4
893 BLADDER CANCER 4
894 BLADDER DISORDER 4
895 BLOOD ALBUMIN DECREASED 4
896 BLOOD CHOLESTEROL ABNORMAL 4
897 BLOOD PRESSURE ABNORMAL 4
898 BLOOD PRESSURE DIASTOLIC DECREASED 4
899 BLOOD URINE PRESENT 4
900 BONE DENSITY DECREASED 4
901 BRAIN NATRIURETIC PEPTIDE INCREASED 4
902 CARDIAC DISCOMFORT 4
903 CENTRAL NERVOUS SYSTEM LESION 4
904 CHOLANGITIS ACUTE 4
905 CHOLECYSTECTOMY 4
906 CHOLESTASIS 4
907 CLAUSTROPHOBIA 4
908 CUTANEOUS SYMPTOM 4
909 DAYDREAMING 4
910 DERMATITIS 4
911 DEVICE KINK 4
912 DISSOCIATIVE DISORDER 4
913 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4
914 DRUG LEVEL DECREASED 4
915 DYSSOMNIA 4
916 ENDOTRACHEAL INTUBATION 4
917 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 4
918 ERECTION INCREASED 4
919 EYE DISCHARGE 4
920 FACE INJURY 4
921 FEELING OF BODY TEMPERATURE CHANGE 4
922 FEELING OF DESPAIR 4
923 FIBULA FRACTURE 4
924 FREQUENT BOWEL MOVEMENTS 4
925 FUNCTIONAL GASTROINTESTINAL DISORDER 4
926 GASTROINTESTINAL MOTILITY DISORDER 4
927 GENERALISED ERYTHEMA 4
928 GRANULOCYTOPENIA 4
929 HAEMORRHAGE URINARY TRACT 4
930 HAIR TEXTURE ABNORMAL 4
931 HEMIPLEGIA 4
932 HEPATIC CYST 4
933 HEPATITIS 4
934 HEPATOCELLULAR CARCINOMA 4
935 HIATUS HERNIA 4
936 HOMICIDAL IDEATION 4
937 HORMONE LEVEL ABNORMAL 4
938 HOSPICE CARE 4
939 HYPERCHOLESTEROLAEMIA 4
940 HYPERTHERMIA 4
941 HYPOMANIA 4
942 HYPOPHOSPHATAEMIA 4
943 HYPOTHERMIA 4
944 HYPOXIA 4
945 ILLUSION 4
946 IMMUNE-MEDIATED CHOLANGITIS 4
947 IMPATIENCE 4
948 INCORRECT DOSE ADMINISTERED BY DEVICE 4
949 INCORRECT PRODUCT ADMINISTRATION DURATION 4
950 INCREASED TENDENCY TO BRUISE 4
951 INJECTION SITE DISCOLOURATION 4
952 INJECTION SITE INFECTION 4
953 INJECTION SITE MASS 4
954 INTERNAL HAEMORRHAGE 4
955 IRRITABLE BOWEL SYNDROME 4
956 JOINT RANGE OF MOTION DECREASED 4
957 LACUNAR INFARCTION 4
958 LIBIDO INCREASED 4
959 LIP EROSION 4
960 LIVER FUNCTION TEST INCREASED 4
961 LOGORRHOEA 4
962 MASS 4
963 MENISCUS INJURY 4
964 MENSTRUAL DISORDER 4
965 METABOLIC ACIDOSIS 4
966 METASTASES TO BONE 4
967 MICTURITION DISORDER 4
968 MOTOR DYSFUNCTION 4
969 MOUTH HAEMORRHAGE 4
970 MOUTH ULCERATION 4
971 MUSCLE ATROPHY 4
972 MUSCLE DISORDER 4
973 MYDRIASIS 4
974 MYOCARDITIS 4
975 NEPHROPATHY 4
976 NERVE INJURY 4
977 NERVOUS SYSTEM DISORDER 4
978 OESOPHAGEAL CARCINOMA 4
979 ONYCHOCLASIS 4
980 ORAL HERPES 4
981 ORAL PAIN 4
982 ORGANISING PNEUMONIA 4
983 OSTEONECROSIS 4
984 PAPULE 4
985 PERSONALITY CHANGE 4
986 PHARYNGITIS STREPTOCOCCAL 4
987 PHOBIA 4
988 PORIOMANIA 4
989 POST PROCEDURAL INFECTION 4
990 POST-ACUTE COVID-19 SYNDROME 4
991 PRODUCT COMPLAINT 4
992 PRODUCT PREPARATION ERROR 4
993 PROSTATITIS 4
994 PULMONARY PAIN 4
995 PYELONEPHRITIS ACUTE 4
996 QUALITY OF LIFE DECREASED 4
997 RASH MACULAR 4
998 REBOUND ACID HYPERSECRETION 4
999 REBOUND EFFECT 4